Bayview Pharmacy is pleased to provide a compounded oral solution of Sodium Phosphate Dibasic Heptahydrate 0.9 Gm/5 ml and Sodium Phosphate Monobasic Monohydrate 2.4 Gm/5 ml. This liquid formulation, consisting of these active ingredients dissolved in a suitable solvent, is intended for oral administration. It offers accurate dosing and convenient delivery of medication, often used when a specific dosage strength or ease of swallowing is required.

This formulation is utilized in the treatment of various disease states, including but not limited to hyperphosphatemia, hypophosphatemia, and metabolic acidosis. The combination of Sodium Phosphate Dibasic Heptahydrate and Sodium Phosphate Monobasic Monohydrate works to restore the body's electrolyte balance, a crucial factor for the proper functioning of the body's organs and systems. Additionally, this formulation is used to treat constipation by increasing the amount of water in the intestines, thereby softening stools and facilitating their passage.

For patients, this formulation is easy to administer and can be taken with or without food. It is crucial to adhere to the instructions provided by your healthcare provider when taking this medication. To prevent dehydration, it is also important to consume plenty of fluids while on this medication.

For prescribers, this formulation serves as an effective treatment for a variety of disease states. It is essential to closely monitor the patient's electrolyte levels while they are on this medication, as it can potentially cause electrolyte imbalances. Monitoring the patient's response to the medication is also crucial, as dosage adjustments may be necessary based on the patient's individual needs.

If you have any queries about this formulation or its application in treating various disease states, please do not hesitate to contact us at Bayview Pharmacy. We are committed to assisting you in finding the most suitable treatment options for your patients.

This Sodium Phosphate Dibasic Heptahydrate 0.9 Gm/5 ml/Sodium Phosphate Monobasic Monohydrate 2.4 Gm/5 ml Oral Solution is a liquid formulation designed for oral administration. It is primarily used to treat a range of conditions including constipation, electrolyte imbalances, and to increase urine output. Additionally, it can be used to manage hyperphosphatemia, hypocalcemia, and hypokalemia.

Patients should be aware that this formulation may cause side effects such as nausea, vomiting, and diarrhea. To prevent dehydration, it is crucial to maintain adequate fluid intake while on this medication. It's also important to note that this medication may interact with other drugs including antacids, diuretics, and laxatives. Therefore, it is essential to inform your healthcare provider about all the medications you are currently taking before starting this treatment.

Special caution should be exercised when prescribing this formulation to patients with kidney disease, as it can potentially exacerbate their condition. Regular monitoring of electrolyte levels is necessary in these patients. Additionally, signs of dehydration should be closely monitored due to the medication's potential to increase urine output.

If you have any queries or concerns about this formulation or its interaction with other medications, do not hesitate to contact your healthcare provider for further information and guidance.

Sodium Phosphate Dibasic Heptahydrate 0.9 Gm/5 ml/Sodium Phosphate Monobasic Monohydrate 2.4 Gm/5 ml Oral Solution is a compounded formulation that combines two distinct types of sodium phosphate salts. The Sodium Phosphate Dibasic Heptahydrate serves as a buffering agent, aiding in the maintenance of the solution's pH balance. On the other hand, Sodium Phosphate Monobasic Monohydrate functions as an osmotic laxative, assisting in stool softening and bowel movement promotion.

This unique combination of salts is primarily used in the treatment of constipation and fecal impaction, as well as in the preparation of the bowel for certain medical procedures. When administered orally, the solution operates by drawing water into the intestines, which aids in stool softening and encourages bowel movements. It is crucial to consume ample fluids while on this medication to prevent dehydration.

The medication is available in a 5 ml oral solution format and should be taken as directed by a healthcare professional. It is vital to adhere to the instructions meticulously and avoid exceeding the recommended dosage. If there are any queries regarding the administration of this medication, it is advisable to consult with a healthcare professional.

The Sodium Phosphate Dibasic Heptahydrate 0.9 Gm/5 ml/Sodium Phosphate Monobasic Monohydrate 2.4 Gm/5 ml Oral Solution is a liquid formulation designed for oral administration. This formulation is composed of one or more active ingredients dissolved in a suitable solvent, ensuring accurate dosing and convenient delivery of medication. It is often utilized when a specific dosage strength or ease of swallowing is required.

This formulation is not only versatile but also effective in treating a variety of conditions. It can be used to treat patients suffering from metabolic acidosis, a condition characterized by excessive acidity in the blood and body tissues. Additionally, it is beneficial for those with hypomagnesemia, a condition marked by low levels of magnesium in the blood.

Patients with hypocalcemia, a condition characterized by low levels of calcium in the blood, can also benefit from this formulation. Similarly, it is effective for those with hypokalemia, a condition marked by low levels of potassium in the blood.

This formulation is also beneficial for patients with hypernatremia, a condition characterized by high levels of sodium in the blood, and those with hypercalcemia, a condition marked by high levels of calcium in the blood. It can also be used to treat patients with hyponatremia, a condition characterized by low levels of sodium in the blood, and those with hypermagnesemia, a condition marked by high levels of magnesium in the blood.

Lastly, this formulation can be used to treat patients with hyperkalemia, a condition characterized by high levels of potassium in the blood, and those with hyperuricemia, a condition marked by high levels of uric acid in the blood. If you have any questions about the use of this formulation for any of these conditions, please reach out for further information.